A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

United States

Children's Hospital Colorado., Denver, Colorado

Argentina

Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Ciudad Autonoma Buenos Aires

Clinica Universitaria Reina Fabiola, Córdoba

China

Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong

Children's Hospital of Fudan University, Shanghai, Shanghai Municipality